| NOMURA FUNDS IRELAND - AMERICAN CENTURY EMERGING MARKETS EQUITY FUND A USD | RVI EMERGENTES | 20,47% | 79,10% | 22,70% | · |
| TOP CLASS HEALTHCARE, FI | RVI SALUD | 20,47% | 26,49% | 16,90% | · |
| VANGUARD EMERGING MARKETS STOCK INDEX INSTITUTIONAL PLUS GBP CAP | RVI EMERGENTES | 20,47% | 74,20% | 42,06% | 109,75% |
| WELLINGTON GLOBAL EQUITY INCOME FUND N Q2 USD DIS | RVI GLOBAL | 20,47% | 53,21% | · | · |
| AMUNDI CORE MSCI EMERGING MARKETS IE CAP | RVI EMERGENTES | 20,46% | 73,85% | 42,06% | · |
| DWS INVEST NET ZERO TRANSITION XC | RVI GLOBAL | 20,46% | · | · | · |
| GOLDMAN SACHS GLOBAL SMALL CAP CORE EQUITY PORTFOLIO I (SNAP) USD CAP | RVI GLOBAL SMALL/MID CAP | 20,46% | 77,09% | 67,13% | 190,81% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 20,46% | 36,95% | -17,57% | · |
| UBS (LUX) EQUITY SICAV - EUROPEAN OPPORTUNITY UNCONSTRAINED (EUR) Q-ACC | RVI EUROPA | 20,46% | 47,66% | 30,15% | 130,69% |
| BGF WORLD HEALTHSCIENCE I2 JPY | RVI BIOTECNOLOGÍA | 20,45% | 29,89% | 38,58% | · |
